Joshua Frenster

Affiliations: 
2016-2022 Neurosurgery New York University School of Medicine, New York, NY, United States 
Google:
"Joshua Frenster"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Frenster JD, Erdjument-Bromage H, Stephan G, et al. (2023) PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. Cell Reports. 42: 112679
Stephan G, Erdjument-Bromage H, Liu W, et al. (2023) Modulation of GPR133 (ADGRD1) Signaling by its Intracellular Interaction Partner Extended Synaptotagmin 1 (ESYT1). Biorxiv : the Preprint Server For Biology
Stephan G, Frenster JD, Liebscher I, et al. (2022) Activation of the adhesion G protein-coupled receptor GPR133 (ADGRD1) by antibodies targeting its N-terminus. The Journal of Biological Chemistry. 101949
Yu JR, LeRoy G, Bready D, et al. (2021) The H3K36me2 writer-reader dependency in H3K27M-DIPG. Science Advances. 7
Frenster JD, Stephan G, Ravn-Boess N, et al. (2021) Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling. The Journal of Biological Chemistry. 100798
Cui X, Ma C, Vasudevaraja V, et al. (2020) Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife. 9
Frenster JD, Desai S, Placantonakis DG. (2020) evidence for glioblastoma cell death in temperatures found in the penumbra of laser-ablated tumors. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 37: 20-26
Frenster JD, Kader M, Kamen S, et al. (2020) Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes. Neuro-Oncology Advances. 2: vdaa053
Spino M, Kurz SC, Chiriboga L, et al. (2018) Cell surface Notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase mutant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Frenster JD, Placantonakis DG. (2018) Bioluminescent In Vivo Imaging of Orthotopic Glioblastoma Xenografts in Mice. Methods in Molecular Biology (Clifton, N.J.). 1741: 191-198
See more...